1. Delivery methods to increase cellular uptake and immunogenicity of DNA vaccines
- Author
-
Branka Grubor-Bauk, Danushka K. Wijesundara, Eric J. Gowans, and S.H.T. Jorritsma
- Subjects
0301 basic medicine ,Human immunodeficiency virus (HIV) ,Antigen-Presenting Cells ,Biology ,medicine.disease_cause ,Injections, Intramuscular ,DNA vaccination ,Mice ,03 medical and health sciences ,Delivery methods ,chemistry.chemical_compound ,Immunogenicity, Vaccine ,Subcutaneous Absorption ,Vaccines, DNA ,medicine ,Animals ,Humans ,Dna delivery ,General Veterinary ,General Immunology and Microbiology ,Immunogenicity ,Vaccination ,Public Health, Environmental and Occupational Health ,Biolistics ,Virology ,Electroporation ,030104 developmental biology ,Infectious Diseases ,chemistry ,Liposomes ,Molecular Medicine ,DNA - Abstract
DNA vaccines are ideal candidates for global vaccination purposes because they are inexpensive and easy to manufacture on a large scale such that even people living in low-income countries can benefit from vaccination. However, the potential of DNA vaccines has not been realized owing mainly to the poor cellular uptake of DNA in vivo resulting in the poor immunogenicity of DNA vaccines. In this review, we discuss the benefits and shortcomings of several promising and innovative non-biological methods of DNA delivery that can be used to increase cellular delivery and efficacy of DNA vaccines.
- Published
- 2016
- Full Text
- View/download PDF